![]() |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
By The Online Investor Staff, updated Thu., Mar. 30, 7:05 PM
|
This Slide: #25 of 25 |
Company:
Option Care Health, Inc. (NASDAQ:OPCH)
Date announced:
3/1/2023
Shares Offered:
13,000,000
Date of Pricing:
3/1/2023
Price Per Share:
$30.75
Secondary Offering Details:
Option Care Health, Inc. ("Option Care Health" or the "Company") (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the "Selling Stockholder") has agreed to sell 13,000,000 shares of the Company's common stock in an underwritten secondary offering. The Company will not receive any proceeds from the offering. -updated 3/1- Option Care Health, Inc. ("Option Care Health" or the "Company") (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the "Selling Stockholder") has agreed to sell 13,000,000 shares of the Company's common stock at a price to the public of $30.75 per share in an underwritten secondary offering. The offering is expected to close on March 3, 2023, subject to customary closing conditions. The Company will not receive any proceeds from the offering.
Option Care Health is an independent provider of home and alternate site infusion services. Co.'s infusion services include the clinical management of infusion therapy, nursing support and care coordination. Co.'s team of clinicians, including pharmacists, pharmacy technicians, nurses and dietitians, are able to provide infusion service coverage for nearly all patients across the U.S. needing treatment for medical conditions. Co.'s services include: Anti-Infectives Infusion; Nutrition Support Infusion; Immunoglobulin Infusion; Chronic Inflammatory Disorders; Neurological Disorders; Bleeding Disorders Infusion; Women's Health; Heart Failure; and others.
OPCH SEC Filing Email Alerts Service
Open the OPCH Page at The Online Investor »
|
Open the OPCH Page at The Online Investor (in a new window) »
![]() ![]() Get SEC Filing Alerts Get Dividend Alerts ![]() ![]() |
![]() Strong Buy (4.00 out of 4) 82nd percentile
(ranked higher than approx. 82% of all stocks covered)
Analysts' Target Price: OPCH Stock Forecast Based on Zacks ABR data; powered by Xignite ![]() |